Anavex Life Sciences
AVXL
58 hedge funds and large institutions have $28.4M invested in Anavex Life Sciences in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 15 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.14% more ownership
Funds ownership: 22.93% → 23.07% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 65 → 58 (-7)
13% less capital invested
Capital invested by funds: $32.6M → $28.4M (-$4.27M)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
68% less call options, than puts
Call options by funds: $264K | Put options by funds: $818K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$852K |
| 2 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$141K |
| 3 |
State Street
Boston,
Massachusetts
|
+$116K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$109K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$99.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$537K |
| 2 |
Bank of New York Mellon
New York
|
-$159K |
| 3 |
Millennium Management
New York
|
-$145K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$88.2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$86.5K |
AVXL Hedge Fund Activity: Q1 2018 in Review
58 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2018, worth a combined $28.4M — down 13% from $32.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AVXL and 8 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 15 added.
The largest buyer was Park West Asset Management, adding an estimated $852K. The largest seller was Susquehanna International Group, cutting an estimated $537K.
- 58 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2018, down from 65 in Q4 2017.
- Funds reported $28.4M of Anavex Life Sciences stock for Q1 2018, down 13% quarter-over-quarter.
- 8 funds opened new Anavex Life Sciences positions in Q1 2018 and 15 closed out, a net change of -7 holders.
- The largest Anavex Life Sciences buyer in Q1 2018 was Park West Asset Management, an estimated $852K added.
- The largest Anavex Life Sciences seller in Q1 2018 was Susquehanna International Group, an estimated $537K sold.
Based on aggregated 13F filings for Q1 2018.